NU9-10803-49892
4 vaccinations
7 coded responses
37 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
KDZ-22199-43261
Child or adolescent in my care · Female · 2022-07-09
Timeline
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 1 — Pfizer-BioNTech
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-04
- 2021-03-05
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-06-18
- 2021-09-17
-
2021-10-22
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-19
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-16
-
2022-09-17
Survey response — days 1–6 daily, dose 4MedDRA: Feeling hot, Hyperhidrosis — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Overheating, sweatingMedDRA releases: 2024-11 · check-in free text available
- 2022-09-18
-
2022-09-19
Survey response — days 1–6 daily, dose 4MedDRA: Chest pain — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Chest painMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Report sent to call center — days 1–6 daily, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-09-20
- 2022-09-20
- 2022-09-21
- 2022-09-23
-
2022-09-30
Survey response — day 14, dose 4MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Survey response — day 21, dose 4MedDRA: Nasal congestion — Feeling: FairFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Survey response — day 28, dose 4MedDRA: Haemorrhage in pregnancy, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Bleeding in pregnancy · Healthcare visit (other): Fertility doctor visits, ultrasoundsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Report sent to call center — day 28, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-10-18
- 2022-10-18
-
2022-10-21
Survey response — day 35, dose 4MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Report sent to call center — day 35, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-24
- 2022-10-24
- 2022-10-24
- 2022-10-28
-
2023-03-17
Survey response — 6 months, dose 4MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-17
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2023-03-20
- 2023-03-20
- 2023-03-20
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-19 | Unsuccessful | |
| 2022-10-14 | Unsuccessful | |
| 2022-10-21 | Unsuccessful | |
| 2023-03-17 | Unsuccessful |
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Overheating, sweating
Systemic reaction (other): Chest pain
Release 12 — day 14, dose 4
Symptoms: Sore throat
Release 12 — day 21, dose 4
Symptoms: Stuffy nose
Release 12 — day 28, dose 4
Symptoms: Bleeding in pregnancy
Healthcare visit (other): Fertility doctor visits, ultrasounds
Release 12 — day 35, dose 4
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Haemorrhage in pregnancy | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Feeling hot | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release